These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4349352)

  • 1. Studies on the neutralization of herpes simplex virus. VI. The mode of action of complement upon antibodysensitized virus.
    Yoshino K; Kishie T
    Jpn J Microbiol; 1973 Jan; 17(1):63-70. PubMed ID: 4349352
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the neutralization of herpes simplex virus. V. Significance of the unneutralizable persistent fraction.
    Yoshino K; Morishima T
    Jpn J Microbiol; 1972 Mar; 16(2):125-36. PubMed ID: 4341629
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the neutralization of herpes simplex virus. VII. Reevaluation of the equilibrium theory concerning the unneutralizable persistent fraction.
    Ide K; Yoshino K
    Jpn J Microbiol; 1974 Sep; 18(5):397-406. PubMed ID: 4374567
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
    Kawana T; Yoshino K; Kasamatsu T
    Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
    [No Abstract]   [Full Text] [Related]  

  • 5. Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies.
    Lerner AM; Shippey MJ; Crane LR
    J Infect Dis; 1974 Jun; 129(6):623-36. PubMed ID: 4365944
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneity in the ability of rabbit 7S and 19S neutralizing antibodies to differentiate between intratypic antigenic variants of Herpes simplex virus.
    Hampar B; Mage MG; Keehn MA
    J Immunol; 1968 Aug; 101(2):256-61. PubMed ID: 4299203
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus.
    Snyderman R; Wohlenberg C; Notkins AL
    J Infect Dis; 1972 Aug; 126(2):207-9. PubMed ID: 4340929
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune inhibition of virus release from herpes simplex virus-infected cells.
    Skinner GR; Mushi EZ; Whitney JE
    Intervirology; 1975-1976; 6(4-5):296-308. PubMed ID: 186438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement.
    Yoshino K; Hashimoto M; Shinkai K
    Microbiol Immunol; 1977; 21(4):231-41. PubMed ID: 195185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.
    Hampar B; Notkins AL; Mage M; Keehn MA
    J Immunol; 1968 Mar; 100(3):586-93. PubMed ID: 4296105
    [No Abstract]   [Full Text] [Related]  

  • 12. Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.
    Powell KL; Buchan A; Sim C; Watson DH
    Nature; 1974 May; 249(455):360-1. PubMed ID: 4135313
    [No Abstract]   [Full Text] [Related]  

  • 13. Late 19S rabbit antibody neutralization test for differentiating herpes simplex virus types 1 and 2.
    Hampar B; Martos LM; Chakrabarty M; Burroughs MA
    J Immunol; 1970 Mar; 104(3):593-8. PubMed ID: 4314178
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.
    Lesso J; Hána L; Matis J
    Acta Virol; 1976 Feb; 20(1):48-52. PubMed ID: 7940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of staphylococcal protein A on complement-potentiated neutralization of herpes simplex virus and immune lysis of virus-infected cells.
    Austin RM; Daniels CA
    Infect Immun; 1975 Oct; 12(4):821-7. PubMed ID: 172447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement requirement of neutralizing antibodies appearing after primary and booster immunizations with herpes simplex virus.
    Yoshino K; Morishima T; Aoki Y
    Jpn J Microbiol; 1971 Jan; 15(1):53-62. PubMed ID: 4323885
    [No Abstract]   [Full Text] [Related]  

  • 18. Further simplification of the serum neutralization test with herpes simplex virus.
    Hondo R; Yoshino K
    Jpn J Microbiol; 1972 Jul; 16(4):321-7. PubMed ID: 4347156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-idiotypic antibodies to the herpes simplex type-1 virus neutralize the virus' infectious activity].
    Kushch AA; Posevaia TA; Simonov VI; Daniliuk OS; Barinskiĭ IF
    Vopr Virusol; 1991; 36(4):312-5. PubMed ID: 1665620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE APPEARANCE OF COMPLEMENT-REQUIRING NEUTRALIZING ANTIBODIES BY IMMUNIZATION AND INFECTION WITH HERPES SIMPLEX VIRUS.
    YOSHINO K; TANIGUCHI S
    Virology; 1964 Feb; 22():193-201. PubMed ID: 14165324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.